Myasthenia gravis with thymus hyperplasia and pure red cell aplasia

Journal of the Neurological Sciences

Volumn 224, Issue 1-2, 2004, Pages 93-95

  Suto, Yutaka ^a   Araga, Shigeru ^a   Sakuma, Kenji ^a   Nakano, Toshiya ^a   Ishiga, Kiyomi ^a   Tajima, Fumito ^a   Kowa, Hisanori ^a   Nakashima, Kenji ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Erythropoietin; Myasthenia gravis; Pure red cell aplasia; Thymus hyperplasia

Indexed keywords

CYCLOSPORIN A; METHYLPREDNISOLONE; PREDNISOLONE; PYRIDOSTIGMINE;

ADULT; ANEMIA; ARTICLE; BLOOD EXAMINATION; BONE MARROW EXAMINATION; CASE REPORT; DIAGNOSTIC PROCEDURE; DRUG PULSE THERAPY; ERYTHROCYTE APLASIA; FEMALE; HISTOLOGY; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; LYMPHOID HYPERPLASIA; MYASTHENIA GRAVIS; PRIORITY JOURNAL; THYMECTOMY; THYMUS HYPERPLASIA; TISSUE SECTION;

CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; MYASTHENIA GRAVIS; RED-CELL APLASIA, PURE; THYMECTOMY; THYMUS HYPERPLASIA;

EID: 4644360129     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2004.06.003     Document Type: Article

References (25)

1. Fambrough D.M., Drachman D.B., Satyamurti S. Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors. Science. 182:1973;293-295
2. Patrick J., Lindstrom J. Autoimmune response to acetylcholine receptor. Science. 180:1973;871-872
3. Vincent A. Unvelling the pathogenesis of myasthenia gravis. Nat. Rev. 2:2002;797-804
4. Murakawa T., Nakajima J., Sato H., Tanaka M., Takamoto S., Fukayama M. Thymoma associated with pure red-cell aplasia: clinical features and prognosis. Asian Cardiovasc. Thorac. Ann. 10:2002;150-154
5. Bailey R.O., Dunn H.G., Rubin A.M., Ritaccio A.L. Myasthenia gravis with thymoma and pure red blood cell aplasia. Am. J. Clin. Pathol. 89:1988;687-693
6. Vincent A., Palace J., Hilton-Jones D. Myasthenia gravis. Lancet. 357:2001;2122-2128
7. Rosenow E.C. III, Hurley B.T. Disorders of the thymus. A review. Arch. Intern. Med. 144:1984;763-770
8. Wong K.F., Chau K.F., Chan J.K., Chu Y.C., Li C.S. Pure red cell aplasia associated with thymic lymphoid hyperplasia and secondary erythropoietin resistance. Am. J. Clin. Pathol. 103:1995;346-347
9. Kornfeld P., Glass J., Papatestas A.E., Horowitz S.H., Matta R., Genkins G. Case report: Thymectomy-induced remission of acquired autoimmune hemolytic anemia in an adult with myasthenia gravis. Am. J. Med. Sci. 277:1979;111-116
10. Krol T.C. Myasthenia gravis, pernicious anemia, and Hashimoto's thyroiditis. Arch. Neurol. 36:1979;594-595
11. Murase T. Bilineage hematopoietic inhibitor and T lymphocyte dysfunction in a patient with pure red cell aplasia, myasthenia gravis and thymoma. Exp. Hematol. 21:1993;451-455
12. Fisch P., Handgretinger R., Schaefer H.E. Pure red cell aplasia. Br. J. Haematol. 111:2000;1010-1022
13. Heegaard E.D., Brown K.E. Human parvovirus B19. Clin. Microbiol. Rev. 15:2002;485-505
14. Rameshwar P., Ramkissoon S.H., Sundarrarajan S., Gascon P. Defect in lymphoid compartment might account for CD8+-deidated effects in the pathophysiology of pure red cell aplasia. Clin. Immunol. 108:2003;248-256
15. Crosti F., Armanini M., Confalonieri P., Antozzi C., Mantegazza R. Changes in peripheral blood lymphocyte subset frequencies in myasthenia gravis patients are related to immunosuppression. J. Neurol. 241:1994;218-222
16. Masuda M., Arai Y., Okamura T., Mizoguchi H. Pure red cell aplasia with thymona: evidence of T-cell clonal disorder. Am. J. Hematol. 54:1997;324-328
17. Gronseth G.S., Barohn R.J. Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 55:2000;7-15
18. Schluep M., Willcox N., Vincent A., Dhoot G.K., Newsom-Davis J. Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study. Ann. Neurol. 22:1987;212-222
19. Salmon A.M., Bruand C., Cardona A., Changeux J.P., Berrih-Aknin S. An acetylcholine receptor alpha subunit promoter confers intrathymic expression in transgenic mice. Implications for tolerance of a transgenic self-antigen and for autoreactivity in myasthenia gravis. J. Clin. Invest. 101:1998;2340-2350
20. Scadding G.K., Vincent A., Newsom-Davis J., Henry K. Acetylcholine receptor antibody synthesis by thymic lymphocytes: correlation with thymic histology. Neurology. 31:1981;935-943
21. Aarli J.A., Stefansson K., Marton L.S., Wollmann R.L. Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin. Clin. Exp. Immunol. 82:1990;284-288
22. Mygland A., Tysnes O.B., Matre R., Volpe P., Aarli J.A., Gilhus N.E. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma. Ann. Neurol. 32:1992;589-591
23. Zeok J.V., Todd E.P., Dillon M., DeSimone P., Utley J.R. The role of thymectomy in red cell aplasia. Ann. Thorac. Surg. 28:1979;257-260
24. Masaoka A., Hashimoto T., Shibata K., Yamakawa Y., Nakamae K., Iizuka M. Thymomas associated with pure red cell aplasia. Histologic and follow-up studies. Cancer. 64:1989;1872-1878
25. Ritchie D.S., Underhill C., Grigg A.P. Aplastic anemia as a late complication of thymoma in remission. Eur. J. Haematol. 68:2002;389-391